Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study aims at testing for the impact of glutamatergic changes on drug craving in cocaine
addiction, and to evaluate the effects of n-acetylcysteine (n-AC) on both glutamate
homeostasis and craving using a randomized, double-blind, placebo controlled cross-over
design.
Phase:
Phase 4
Details
Lead Sponsor:
Psychiatric University Hospital, Zurich
Collaborators:
Max-Planck-Institut Tübingen Swiss Federal Institute of Technology Zurich Center for Integrative Human Physiology